—
In Q2 FY26, Sales Increased 16.6% YOY to $221.3 Million; New Products Sales Grew ~13% and Sales into Fast Growth Markets Contributed ~28% of Total Sales
—
In Q2 FY26, Sales Increased 6.4% YOY Organically; Electronics Increased 11.1% YOY Organically
—
Record Quarterly Order Intake with Book to Bill of 1.04; Electronics Book to Bill of 1.08
—
Q2 FY26 GAAP Operating Margin of 16.1%; Adjusted Operating Margin of 19.0%, Up 30 bps YOY
—
Reiterating FY26 Sales Outlook of >$110 Million Over FY25; Fast Growth Market Sales to Grow >45% and Exceed $270 Million; Plan to Release >15 New Products, Contributing ~300 bps of Growth
Standex International Corporation (NYSE: SXI) today reported financial results for the second quarter of fiscal year 2026 ended December 31, 2025.
Summary Financial Results - Total ($M except EPS and Dividends) 2Q26 2Q25 1Q26 Y/Y Q/Q Net Sales $221.3 $189.8 $217.4 16.6 % 1.8 % Operating Income - GAAP $35.6 $8.5 $29.6 320.3 % 20.0 % Operating Income - Adjusted $42.2 $35.5 $41.6 18.9 % 1.4 % Operating Margin % - GAAP 16.1 % 4.5 % 13.6 % + 1160 bps + 250 bps Operating Margin % - Adjusted 19.0 % 18.7 % 19.1 % + 30 bps -10 bps Net Income from Continuing Ops - GAAP $20.6 $1.3 $15.8 1,501.9 % 30.4 % Net Income from Continuing Ops - Adjusted $25.1 $22.9 $24.0 9.5 % 4.3 % EBITDA $45.1 $16.1 $39.7 180.3 % 13.5 % EBITDA margin 20.4 % 8.5 % 18.3 % + 1190 bps + 210 bps Adjusted EBITDA $47.2 $39.6 $47.1 19.2 % 0.2 % Adjusted EBITDA margin 21.3 % 20.9 % 21.7 % + 40 bps -40 bps Diluted EPS - GAAP $0.17 $0.07 $1.25 145.6 % -86.4 % Diluted EPS - Adjusted $2.08 $1.91 $1.99 8.9 % 4.5 % Dividends per Share $0.34 $0.32 $0.32 6.3 % 6.3 % Free Cash Flow $13.0 $2.2 $10.4 506.5 % 25.5 % Net Debt to EBITDA 2.3x 2.9x 2.4x -20.8 % -5.8 %
*Adjusted operating income, adjusted operating margin, and adjusted EPS for all periods now also exclude amortization expense from acquired intangible assets.
Commenting on the quarter’s results, President and Chief Executive Officer David Dunbar said, “We delivered strong top-line results and operating performance in the fiscal second quarter. Our sales increased 16.6% year-on-year to $221.3 million driven by 7% contribution from new products and 28% contribution from sales into fast growth markets. We recorded 6.4% organic growth and book to bill of 1.04, led by our Electronics segment which grew 11.1% organically with book to bill of 1.08. We are well positioned to deliver mid-to-high single digit organic growth in the fiscal third quarter, primarily driven by new product launches, strong tailwinds in the electrical grid, defense and aviation end markets, and improving general industrial markets. Sales from fast growth markets totaled approximately $61 million in the fiscal second quarter and are expected to exceed $270 million in fiscal year 2026.
Adjusted operating margin expanded 30 basis points year-on-year to 19.0%. We paid down approximately $10 million of debt in the fiscal second quarter, and our net leverage ratio was reduced to 2.3x.”
Fiscal Third Quarter 2026 Outlook
In fiscal third quarter 2026, on a year-on-year basis, the Company expects significantly higher revenue, driven by mid-to- high single digit organic growth from higher sales into fast growth end markets and increased new product sales, and slightly higher adjusted operating margin due to higher volume and favorable product mix, partially offset by growth investments and higher medical costs.
On a sequential basis, the Company expects slightly to moderately higher revenue, driven by increased contributions from fast growth end markets and new product sales, and slightly to moderately higher adjusted operating margin due to higher volume and pricing and productivity initiatives, partially offset by growth investments.
Fiscal Year 2026 Outlook
The Company is reiterating its fiscal year 2026 sales outlook. In fiscal year 2026, barring any unforeseen economic, global trade, or tariffs related disruptions, the Company expects revenue to grow by over $110 million, driven by mid-to-high single digit organic growth in Electronics, double-digit organic growth in Engineering Technologies, and the contribution from recent acquisitions. The Company remains on course to release over fifteen new products that it expects will contribute approximately 300 bps of incremental growth. Sales from fast growth markets are on track to grow over 45% year-on-year and exceed $270 million. The Company expects continued adjusted operating margin expansion in fiscal year 2026.
Second Quarter Segment Operating Performance
Electronics (52
% of sales; 63% of segment adjusted operating income)
2Q26 2Q25 % Change
Electronics ($M)
Revenue 115.7 95.9 20.6 %
GAAP Operating Income 29.8 17.4 70.9 %
GAAP Operating Margin % 25.7 18.2
Adjusted Operating Income* 33.3 26.5 25.7 %
Adjusted Operating Margin %* 28.8 27.6
* Excludes the amortization of acquired intangible assets; Q2 FY25 restated to exclude the amortization of acquired intangible assets
Revenue increased approximately $19.7 million or 20.6% year-on-year, reflecting organic growth of 11.1%, an acquisition benefit of 9.1%, and a foreign currency benefit of 0.4%. Organic growth was driven by sales into fast growth markets and increased new product sales. Adjusted operating income increased approximately $6.8 million or 25.7% year-on-year due to higher volume, pricing initiatives, and product mix.
The segment had a book-to-bill ratio of approximately 1.08 in the fiscal second quarter, with orders of approximately $125 million.
In fiscal third quarter 2026, on a sequential basis, the Company expects slightly to moderately higher revenue, reflecting higher sales into fast growth end markets and increased new product sales. The Company expects similar adjusted operating margin, primarily due to product mix and continued strategic growth investments.
Engineering Technologies (14% of sales; 11% of segment adjusted operating income
)
2Q26 2Q25 % Change
Engineering Technologies ($M)
Revenue 30.6 22.7 35.3 %
GAAP Operating Income 4.4 3.7 18.6 %
GAAP Operating Margin % 14.3 16.3
Adjusted Operating Income* 5.8 3.7 56.6 %
Adjusted Operating Margin %* 18.9 16.3
* Excludes the amortization of acquired backlog and acquired intangible assets
Revenue increased approximately $8.0 million or 35.3% year-on-year reflecting a 33.4% benefit from the McStarlite acquisition, organic growth of 1.2%, and a foreign currency benefit of 0.6%. Organic growth was suppressed by delays in customer project timing. Adjusted operating income increased approximately $2.1 million or 56.6% year-on-year reflecting higher volume.
In fiscal third quarter 2026, on a sequential basis, the Company expects moderately to significantly higher revenue, due to growth in new product sales and more favorable project timing, and slightly to moderately higher adjusted operating margin due to higher volume.
Scientific
(9% of sales; 9% of segment adjusted operating income)
2Q26 2Q25 % Change
Scientific ($M)
Revenue 19.5 18.5 5.5 %
GAAP Operating Income 4.5 4.7 -4.9 %
GAAP Operating Margin % 23.0 25.5
Adjusted Operating Income* 4.7 5.0 -4.9 %
Adjusted Operating Margin %* 24.2 26.9
* Excludes the amortization of acquired intangible assets; Q2 FY25 restated to exclude the amortization of acquired intangible assets
Revenue increased approximately $1.0 million or 5.5% year-on-year reflecting an acquisition benefit of 8.1%, partially offset by an organic decline of 2.6% from lower demand at academic and research institutions that were impacted by NIH funding cuts. Adjusted operating income decreased approximately $0.2 million or 4.9% year-on-year due to the organic decline partially offset by contribution from the acquisition.
In fiscal third quarter 2026, on a sequential basis, the Company expects similar revenue and slightly lower adjusted operating margin due to product mix, investments in research and development, and tariff costs, partially offset by pricing and productivity initiatives.
Engraving (16% of sales; 13% of segment adjusted operating income)
2Q26 2Q25 % Change
Engraving ($M)
Revenue 35.7 31.5 13.6 %
GAAP Operating Income 6.6 4.1 59.3 %
GAAP Operating Margin % 18.4 13.1
Adjusted Operating Income* 6.8 4.5 52.4 %
Adjusted Operating Margin %* 19.2 14.3
* Excludes the amortization of acquired intangible assets; Q2 FY25 restated to exclude the amortization of acquired intangible assets
Revenue increased approximately $4.3 million or 13.6% year-on-year reflecting organic growth of 10.3% from improved demand in Europe and North America and a foreign currency benefit of 3.3%. Adjusted operating income increased approximately $2.4 million or 52.4% year-on-year due to higher sales and the realization of previously announced productivity initiatives and restructuring actions.
In fiscal third quarter 2026, on a sequential basis, the Company expects similar revenue and slightly lower adjusted operating margin due to project and regional mix.
Specialty Solutions
(9% of sales; 4% of segment adjusted operating income)
2Q26 2Q25 % Change
Specialty Solutions ($M)
Revenue 19.8 21.3 -7.2 %
Operating Income 2.1 3.6 -40.7 %
Operating Margin % 10.7 16.7
Specialty Solutions revenue decreased approximately $1.5 million or 7.2% year-on-year. Operating income decreased approximately $1.5 million or 40.7% year-on-year.
In fiscal third quarter 2026, on a sequential basis, the Company expects moderately to significantly higher revenue and operating margin.
Capital Allocation
—
Interest: In fiscal third quarter 2026, the Company expects interest expense between $7 million and $7.5 million.
—
Share Repurchase: During the fiscal second quarter of 2026, the Company did not repurchase shares. There was approximately $28 million remaining on the Company’s current share repurchase authorization at the end of the fiscal second quarter 2026.
—
Capital Expenditures: In fiscal second quarter 2026, the Company’s capital expenditures were $7.7 million compared to $7.0 million in the fiscal second quarter of 2025. The Company expects fiscal year 2026 capital expenditures between $33 million and $38 million. Capital expenditures were $28.3 million in fiscal year 2025.
—
Dividend: On January 23, 2026, the Company declared a quarterly cash dividend of $0.34 per share, an approximately 6.3% year-on-year increase. The dividend is payable February 27, 2026, to shareholders of record on February 13, 2026.
Balance Sheet and Cash Flow Highlights
—
Net Debt: Standex had net (cash) debt of $437.7 million on December 31, 2025, compared to $413.2 million at the end of fiscal second quarter 2025. Net (cash) debt for the second quarter of 2026 consisted primarily of long-term debt of $534.7 million and cash and equivalents of $97.0 million.
—
Cash Flow: Net cash provided by continuing operating activities for the three months ended December 31, 2025, was $20.7 million compared to $9.1 million in the prior year’s quarter. Free cash flow after capital expenditures was $13.0 million compared to free cash flow after capital expenditures of $2.2 million in the fiscal second quarter of 2025.
Conference Call Details
Standex will host a conference call for investors tomorrow, January 30, 2026, at 8:30 a.m. ET. On the call, David Dunbar, President and CEO, and Ademir Sarcevic, CFO, will review the Company’s financial results and business and operating highlights. Investors interested in listening to the webcast and viewing the slide presentation should log on to the “Investors” section of Standex’s website under the subheading, “Events and Presentations,” located at www.standex.com.
A replay of the webcast will also be available on the Company’s website shortly after the conclusion of the presentation online through January 30, 2027. To listen to the teleconference playback, please dial in the U.S. (888) 660-6345 or (646) 517-4150 internationally; the passcode is 80581#. The audio playback via phone will be available through February 6, 2026. The webcast replay can be accessed in the “Investor Relations” section of the Company’s website, located at www.standex.com.
Use of Non-GAAP Financial Measures
In addition to the financial measures prepared in accordance with generally accepted accounting principles (“GAAP”), the Company uses certain non-GAAP financial measures, including non-GAAP adjusted income from operations, non-GAAP adjusted net income from continuing operations, free operating cash flow, EBITDA (earnings before interest, taxes, depreciation and amortization) adjusted EBITDA, adjusted EBITDA to net debt, and adjusted earnings per share. The attached financial tables reconcile non-GAAP measures used in this press release to the most directly comparable GAAP measures. The Company believes that the use of non-GAAP measures which exclude the impact of restructuring charges, purchase accounting, amortization from acquired intangible assets, insurance recoveries, discrete tax events, gain or loss on sale of a business unit, acquisition costs, and litigation costs help investors to obtain a better understanding of our operating results and prospects, consistent with how management measures and forecasts the Company’s performance, especially when comparing such results to previous periods. An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. Non-GAAP measures should be considered in addition to, and not as a replacement for, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.
About Standex
Standex International Corporation
is a multi-industry manufacturer in five broad business segments: Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions with operations in the United States, Europe, Canada, Japan, Singapore, Mexico, Turkey, India, and China. For additional information, visit the Company’s website at http://standex.com/.
Forward-Looking Statements
Statements contained in this Press Release that are not based on historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as “should,” “could,” “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company’s business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include, but are not limited to: the impact of global crises or catastrophic events on employees, our supply chain, and the demand for our products and services around the world; materially adverse or unanticipated legal judgments, fines, penalties or settlements; conditions in the financial and banking markets, including fluctuations in exchange rates and the inability to repatriate foreign cash; domestic and international economic conditions, including the impact, length and degree of economic downturns on the customers and markets we serve and more specifically conditions in the electrical grid, automotive, construction, aerospace, defense, transportation, food service equipment, consumer appliance, energy, oil and gas and general industrial markets; lower-cost competition; the relative mix of products which impact margins and operating efficiencies in certain of our businesses; the impact of higher raw material and component costs, particularly steel, certain materials used in electronics parts, petroleum based products, and refrigeration components; the impact of higher transportation and logistics costs, especially with respect to transportation of goods from Asia; the impact of inflation on the costs of providing our products and services; an inability to realize the expected cost savings from restructuring activities including effective completion of plant consolidations, cost reduction efforts including procurement savings and productivity enhancements, capital management improvements, strategic capital expenditures, and the implementation of lean enterprise manufacturing techniques; the potential for losses associated with the exit from or divestiture of businesses that are no longer strategic or no longer meet our growth and return expectations; the inability to achieve the savings expected from global sourcing of raw materials and diversification efforts in emerging markets; the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs; the inability to attain expected benefits from acquisitions and the inability to effectively consummate and integrate such acquisitions and achieve synergies envisioned by the Company; increased costs from acquisitions to improve and coordinate managerial, operational, financial, and administrative systems, including internal controls over financial reporting and compliance with the Sarbanes-Oxley Act of 2002, and other costs related to such systems in connection with acquired businesses; market acceptance of our products; our ability to design, introduce and sell new products and related product components; the ability to redesign certain of our products to continue meeting evolving regulatory requirements; the impact of delays initiated by our customers; our ability to increase manufacturing production to meet demand including as a result of labor shortages; the impact on our operations of any successful cybersecurity attacks; and potential changes to future pension funding requirements. For a more comprehensive discussion of these and other factors, see the “Risk Factors” section of the Company’s most recent annual report on Form 10-K filed with the SEC and available on the Company’s website. In addition, any forward-looking statements represent management’s estimates only as of the day made and should not be relied upon as representing management’s estimates as of any subsequent date. While the Company may elect to update forward-looking statements at some point in the future, the Company and management specifically disclaim any obligation to do so, even if management’s estimates change.
Standex International Corporation
Consolidated Statement of Operations
(unaudited)
Three Months Ended Six Months Ended
December 31, December 31, December 31, December 31,
(In thousands, except per share data) 2025 2024 2025 2024
Net sales $
221,320 189,814 $
438,751 $
360,278
Cost of sales 129,087 118,367 256,086 218,758
Gross profit 92,233 71,447 182,665 141,520
Selling, general and administrative expenses 51,166 42,189 100,998 83,232
Restructuring costs 438 920 6,436 2,006
Amortization of acquired intangible assets 4,439 3,475 8,976 5,480
Acquisition related costs 617 16,400 1,049 18,240
Income from operations 35,573 8,463 65,206 32,562
Interest expense 7,914 5,575 16,826 6,552
Other non-operating (income) expense, net 490 890 225 862
Total 8,404 6,465 17,051 7,414
Income from continuing operations before income taxes 27,169 1,998 48,155 25,148
Provision for income taxes 6,536 710 11,701 5,672
Net income from continuing operations 20,633 1,288 36,454 19,476
Income (loss) from discontinued operations, net of tax 48 (13) 21 (4)
Net income 20,681 1,275 36,475 19,472
Less: net income attributable to redeemable noncontrolling interest 582 418 1,321 418
Less: change of redeemable noncontrolling interest to redemption value 17,979 17,979
Net income attributable to Standex International $
2,120 $
857 $
17,175 $
19,054
Basic earnings per share:
Income (loss) from discontinued operations 0.00 (0.00) 0.00 (0.00)
Total income (loss) attributable to Standex International $
0.17 $
0.07 $
1.43 $
1.60
Diluted earnings per share:
Income (loss) from discontinued operations 0.00 (0.00) 0.00 (0.00)
Total income (loss) attributable to Standex International $
0.17 $
0.07 $
1.42 $
1.59
Average Shares Outstanding
Basic 12,043 11,942 12,027 11,872
Diluted 12,055 12,025 12,073 11,972
Standex International Corporation
Condensed Consolidated Balance Sheets
(unaudited)
December 31, June 30,
(In thousands) 2025 2025
ASSETS
Current assets:
Cash and cash equivalents $
96,998 104,542
Accounts receivable, net 176,628 172,702
Inventories 131,196 129,994
Prepaid expenses and other current assets 85,912 73,641
Total current assets 490,734 480,879
Property, plant, equipment, net 160,378 160,364
Intangible assets, net 212,052 225,757
Goodwill 594,080 610,338
Deferred tax asset 11,687 11,971
Operating lease right-of-use asset 47,835 47,998
Other non-current assets 37,735 29,573
Total non-current assets 1,063,767 1,086,001
Total assets $
1,554,501 $
1,566,880
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $
87,773 88,001
Accrued liabilities 69,403 63,204
Income taxes payable 13,633 15,770
Total current liabilities 170,809 166,975
Long-term debt 534,733 552,515
Operating lease long-term liabilities 37,997 40,057
Accrued pension and other non-current liabilities 66,215 67,743
Total non-current liabilities 638,945 660,315
Redeemable non-controlling interest 44,511 27,913
Stockholders' equity:
Common stock 41,976 41,976
Additional paid-in capital 140,476 136,082
Retained earnings 1,136,096 1,126,851
Accumulated other comprehensive loss (188,019) (164,765)
Treasury shares (430,293) (428,467)
Total stockholders' equity 700,236 711,677
Total liabilities, redeemable noncontrolling interest and stockholders' equity $
1,554,501 $
1,566,880
Standex International Corporation and Subsidiaries
Statements of Consolidated Cash Flows
(unaudited)
Six Months Ended
December 31,
(In thousands) 2025 2024
Cash Flows from Operating Activities
Net income $
36,475 19,472
Income (loss) from discontinued operations 21 (4)
Income from continuing operations 36,454 19,476
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 19,801 15,566
Stock-based compensation 4,838 5,155
Non-cash portion of restructuring charge 149 (896)
Contributions to defined benefit plans (2,796) (4,766)
Net changes in operating assets and liabilities (20,935) (7,873)
Net cash provided by operating activities - continuing operations 37,511 26,662
Net cash provided by (used in) operating activities - discontinued operations (127) (31)
Net cash provided by (used in) operating activities 37,384 26,631
Cash Flows from Investing Activities
Expenditures for property, plant and equipment (14,084) (13,690)
Expenditures for acquisitions, net of cash acquired (419,652)
Other investing activities (5) 3,904
Net cash provided by (used in) investing activities (14,089) (429,438)
Cash Flows from Financing Activities
Proceeds from borrowings 8,000 724,313
Payments of debt (26,000) (339,110)
Contingent consideration payment (330)
Activity under share-based payment plans 1,528 1,791
Purchase of treasury stock and other (3,798) (5,166)
Distributions to non-controlling interests (1,598)
Cash dividends paid (7,930) (7,362)
Other financing activities (4,415)
Net cash provided by (used in) financing activities (30,128) 370,051
Effect of exchange rate changes on cash (711) (300)
Net changes in cash and cash equivalents (7,544) (33,056)
Cash and cash equivalents at beginning of year 104,542 154,203
Cash and cash equivalents at end of period $
96,998 $
121,147
Standex International Corporation
Selected Segment Data
(unaudited)
Three Months Ended Six Months Ended
December 31, December 31,
(In thousands) 2025 2024 2025 2024
Net Sales
---
Electronics $
115,668 $
95,923 $
226,220 $
173,656
Engineering Technologies 30,636 22,649 60,530 43,179
Scientific 19,502 18,477 38,952 36,170
Engraving 35,728 31,454 71,568 64,817
Specialty Solutions 19,786 21,311 41,481 42,456
Total $
221,320 $
189,814 $
438,751 $
360,278
Income from operations
---
Electronics $
29,765 $
17,419 $
58,048 $
34,446
Engineering Technologies 4,377 3,692 7,994 7,702
Scientific 4,488 4,718 9,167 9,467
Engraving 6,568 4,122 13,104 9,946
Specialty Solutions 2,112 3,562 5,000 7,110
Restructuring (438) (920) (6,436) (2,006)
Acquisition related costs (617) (16,400) (1,049) (18,240)
Corporate (10,682) (7,730) (20,622) (15,863)
Total $
35,573 $
8,463 $
65,206 $
32,562
Standex International Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
(unaudited)
Three Months Ended Six Months Ended
December 31, December 31,
(In thousands, except percentages) 2025 2024 % 2025 2024 %
Change Change
Adjusted income from operations and adjusted net income from
continuing operations:
Net Sales $
221,320 $
189,814 16.6 % $
438,751 $
360,278 21.8 %
Income from operations, as reported $
35,573 $
8,463 320.3 % $
65,206 $
32,562 100.3 %
Income from operations margin 16.1 % 4.5 % 14.9 % 9.0 %
Adjustments:
Restructuring charges 438 920 6,436 2,006
Acquisition-related costs 617 16,400 1,049 18,240
Amortization of acquired intangible assets 4,439 3,475 8,976 5,480
Litigation (settlement refund) charge 100 100
Purchase accounting expenses 993 6,197 1,985 6,197
Adjusted income from operations $
42,160 $
35,455 18.9 % $
83,752 $
64,485 29.9 %
Adjusted income from operations margin 19.0 % 18.7 % 19.1 % 17.9 %
Interest and other income (expense), net (8,404) (6,465) (17,051) (7,414)
Foreign currency related (gain) loss on acquisition and
divestiture activities 554 554
Provision for income taxes (6,536) (710) (11,701) (5,672)
Discrete and other tax items 447 375
Tax impact of above adjustments (1,561) (5,958) (4,566) (7,141)
Net income from continuing operations, as adjusted 25,659 23,323 50,434 45,187
Less: net income attributable to redeemable noncontrolling
interest 18,561 418 19,300 418
Add back: change of redeemable noncontrolling interest to (17,979) (17,979)
redemption value per the acquisition agreement
Net income from continuing operations attributable to Standex, as $
25,077 $
22,905 9.5 % $
49,113 $
44,769 9.7 %
adjusted
EBITDA and Adjusted EBITDA:
Net income (loss) from continuing operations, as reported $
20,633 $
1,288 1501.9 % $
36,454 $
19,476
Net income from continuing operations margin 9.3 % 0.7 % 8.3 % 5.4 %
Add back:
Provision for income taxes 6,536 710 11,701 5,672
Interest expense 7,914 5,575 16,826 6,552
Depreciation and amortization 9,984 8,505 19,801 15,566
EBITDA $
45,067 $
16,078 180.3 % $
84,782 $
47,266 79.4 %
EBITDA Margin 20.4 % 8.5 % 19.3 % 13.1 %
Adjustments:
Restructuring charges 438 920 6,436 2,006
Acquisition-related costs 617 16,400 1,049 18,240
Litigation (settlement refund) charge 100 100
Purchase accounting expenses 993 6,197 1,985 6,197
Adjusted EBITDA $
47,214 $
39,595 19.2 % $
94,352 $
73,709 28.0 %
Adjusted EBITDA Margin 21.3 % 20.9 % 21.5 % 20.5 %
Free operating cash flow:
Net cash provided by operating activities - continuing operations, as $
20,703 $
9,115 $
37,511 $
26,662
reported
Less: Capital expenditures (7,664) (6,965) (14,084) (13,690)
Free cash flow from continuing operations $
13,039 $
2,150 $
23,427 $
12,972
Standex International Corporation
Reconciliation of GAAP to Non-GAAP Financial Measures
(unaudited)
Three Months Ended Six Months Ended
Adjusted earnings per share from continuing December 31, December 31,
operations
2025 2024 % 2025 2024 %
Change Change
Diluted earnings per share from continuing operations $
0.17 $
0.07 145.6 % $
1.42 $
1.59 -10.6 %
attributable to Standex, as reported
Adjustments:
Restructuring charges 0.03 0.06 0.39 0.13
Acquisition-related costs 0.04 1.10 0.07 1.22
Amortization of acquired intangible assets 0.28 0.22 0.57 0.35
Gain on bargain purchase
Litigation (settlement refund) charge 0.01 0.01
(Gain) loss on sale of business
Foreign currency related (gain) loss on
acquisition 0.03 0.03
and divestiture activities
Environmental remediation
Discrete tax items 0.04 0.04
Purchase accounting expenses 0.06 0.39 0.13 0.39
Change of redeemable noncontrolling interest
to 1.49 1.49
redemption value per the acquisition
agreement
Diluted earnings per share from continuing operations $
2.08 $
1.91 8.9 % $
4.08 $
3.75 8.8 %
attributable to Standex, as adjusted
View original content to download multimedia:https://www.prnewswire.com/news-releases/standex-reports-fiscal-second-quarter-2026-financial-results-302674423.html
SOURCE Standex International Corporation
https://rt.newswire.ca/rt.gif?NewsItemId=NY74497&Transmission_Id=202601291601PR_NEWS_USPR_____NY74497&DateId=20260129
COMTEX_472581470/1005/2026-01-29T16:01:16